Life Science Sales Director, Luke Marshall from EMEA, provides his insight on the future of SPACs and how the process is still promising for biopharma companies to go public.
Luke Marshall quoted in "Does The SPAC Have A Future In Biopharma?"
To learn more, download the
article
below.
